Page 72 - Read Online
P. 72

Shaha. J Cancer Metastasis Treat 2023;9:22  https://dx.doi.org/10.20517/2394-4722.2022.101  Page 9 of 9

                   Surg Oncol 2018;44:1671-8.  DOI
               11.      Araque KA, Gubbi S, Klubo-Gwiezdzinska J. Updates on the management of thyroid cancer. Horm Metab Res 2020;52:562-77.  DOI
                   PubMed  PMC
               12.      Dismukes J, Fazendin J, Obiarinze R, et al. Prophylactic central neck dissection in papillary thyroid carcinoma: all risks, no reward. J
                   Surg Res 2021;264:230-5.  DOI  PubMed  PMC
               13.      Dolidze DD, Shabunin AV, Mumladze RB, et al. A narrative review of preventive central lymph node dissection in patients with
                   papillary thyroid cancer - a necessity or an excess. Front Oncol 2022;12:906695.  DOI
               14.      Iyer NG, Shaha AR. Controversies and challenges in the management of well-differentiated thyroid cancer. Indian J Surg
                   2009;71:299-307.  DOI  PubMed  PMC
               15.      Moussa AM, Maybody M, Gonzalez-Aguirre AJ, Buicko JL, Shaha AR, Santos E. Thoracic duct embolization in post-neck dissection
                   chylous leakage: a case series of six patients and review of the literature. Cardiovasc Intervent Radiol 2020;43:931-7.  DOI  PubMed
                   PMC
               16.      Shaha AR. Complications of neck dissection for thyroid cancer. Ann Surg Oncol 2008;15:397-9.  DOI  PubMed  PMC
               17.      Hay ID, Lee RA, Davidge-Pitts C, Reading CC, Charboneau JW. Long-term outcome of ultrasound-guided percutaneous ethanol
                   ablation of selected "recurrent" neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma
                   previously treated by surgery and 131I therapy. Surgery 2013;154:1448-54; discussion 1454.  DOI  PubMed
               18.      Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be
                   stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid
                   2012;22:1144-52.  DOI
               19.      Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid
                   nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated
                   thyroid cancer. Thyroid 2016;26:1-133.  DOI
               20.      Tao Y, Wang F, Shen X, et al. BRAF V600E status sharply differentiates lymph node metastasis-associated mortality risk in papillary
                   thyroid cancer. J Clin Endocrinol Metab 2021;106:3228-38.  DOI
   67   68   69   70   71   72   73   74   75   76   77